158 related articles for article (PubMed ID: 38384805)
21. A Practical Nomogram and Risk Stratification System Predicting the Cancer-Specific Survival for Patients With Advanced Hepatocellular Carcinoma.
Yang D; Su Y; Zhao F; Chen C; Zhao K; Xiong X; Ding Y
Front Oncol; 2022; 12():914192. PubMed ID: 35903694
[TBL] [Abstract][Full Text] [Related]
22. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model.
Luo PQ; Ye ZH; Zhang LX; Song ED; Wei ZJ; Xu AM; Lu Z
World J Clin Cases; 2022 Dec; 10(36):13250-13263. PubMed ID: 36683638
[TBL] [Abstract][Full Text] [Related]
24. Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy.
Wu JL; Luo JY; Jiang ZB; Huang SB; Chen GR; Ran HY; Liang QY; Huang MS; Lai LS; Chen JW
World J Gastroenterol; 2023 May; 29(20):3168-3184. PubMed ID: 37346152
[TBL] [Abstract][Full Text] [Related]
25. Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection.
Gao B; Wang MD; Li Y; Huang F
Front Public Health; 2022; 10():949500. PubMed ID: 35991065
[TBL] [Abstract][Full Text] [Related]
26. Novel Nomogram Based on Inflammatory Markers for the Preoperative Prediction of Microvascular Invasion in Solitary Primary Hepatocellular Carcinoma.
Gu Y; Zheng F; Zhang Y; Qiao S
Cancer Manag Res; 2022; 14():895-907. PubMed ID: 35256861
[TBL] [Abstract][Full Text] [Related]
27. Predictive potential of Nomogram based on GMWG for patients with hepatocellular carcinoma after radical resection.
Ren L; Chen D; Xu W; Xu T; Wei R; Suo L; Huang Y; Chen H; Liao W
BMC Cancer; 2021 Jul; 21(1):817. PubMed ID: 34266388
[TBL] [Abstract][Full Text] [Related]
28. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
[TBL] [Abstract][Full Text] [Related]
29. A novel nomogram based on body composition and nutritional indicators to predict the prognosis of patients with muscle-invasive bladder cancer undergoing radical cystectomy.
Zhong X; Pan Y; Wu K; Wang L; Dou P; Tan P; Zhang P; Li X
Cancer Med; 2023 Dec; 12(24):21627-21638. PubMed ID: 37975152
[TBL] [Abstract][Full Text] [Related]
30. A Novel Prognostic Nomogram and Risk Classification System for Predicting Cancer-Specific Survival of Postoperative Fibrosarcoma Patients: A Large Cohort Retrospective Study.
Huang C; Huang Z; Zhou Z
J Oncol; 2022; 2022():7831001. PubMed ID: 36065310
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
32. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
[TBL] [Abstract][Full Text] [Related]
33. Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score.
Yu X; Yang R; He Z; Li K; Zeng P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12013-12024. PubMed ID: 37421461
[TBL] [Abstract][Full Text] [Related]
34. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.
Yuan Z; Wang Y; Hu C; Gao W; Zheng J; Li W
Technol Cancer Res Treat; 2018 Jan; 17():1533033818801362. PubMed ID: 30244651
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase.
Zhan J; Wang J; Zhang Z; Xue R; Jiang S; Liu J; Liu Y; Zhu L; Xia J; Yan X; Ding W; Zhu C; Qiu Y; Li J; Huang R; Wu C
Virulence; 2023 Dec; 14(1):2268497. PubMed ID: 37938933
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of a nomogram for forecasting survival of alcohol related hepatocellular carcinoma patients.
Yan T; Huang C; Lei J; Guo Q; Su G; Wu T; Jin X; Peng C; Cheng J; Zhang L; Liu Z; Kin T; Ying F; Liangpunsakul S; Li Y; Lu Y
Front Oncol; 2022; 12():976445. PubMed ID: 36439435
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial Chemoembolization.
Zhao D; Xu W; Zhan Y; Xu L; Ding W; Xu A; Hou Z; Ni C
Clin Med Insights Oncol; 2023; 17():11795549231178178. PubMed ID: 37378393
[TBL] [Abstract][Full Text] [Related]
39. Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort.
Li Y; Chen T; Fu B; Luo Y; Chen L
Front Oncol; 2023; 13():1164401. PubMed ID: 37397381
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a prognostic nomogram for breast cancer patients who underwent chemoradiotherapy and surgery: a retrospective cohort study based on the SEER database and two Chinese cohorts.
Wang H; Xia GF; Zhang ZR; Luo X; Zhu JY; Wang HK
Am J Cancer Res; 2023; 13(11):5065-5081. PubMed ID: 38058820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]